Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Procollagen-3 driven corticosteroids for persistent ARDS
2017-002867-16Phase 3Terminated
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jul 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of methylprednisolone in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Ventilator-free days to day 60 (VFD60). Started Jul 2017; status: terminated.
02
Drugs
methylprednisolone
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on 2017-002867-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002867-16.